Home > Insider Trading > Filing (0001225208-22-002658)

Filing Details

Accession Number:: 0001225208-22-002658
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-02-17 19:57:33
Reporting Period:: 2022-02-15

Accepted Time:: 2022-02-17 19:57:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885725	Boston Scientific Corp	BSX	Surgical & Medical Instruments & Apparatus (3841)	042695240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1595612	J. Daniel Brennan	300 Boston Scientific Way Marlborough MA 01752-1234	Evp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-02-15	4,153	$0.00	276,532	No	4	M	Direct
Common Stock	Disposition	2022-02-15	1,219	$44.01	275,313	No	4	F	Direct
Common Stock	Disposition	2022-02-15	9,136	$43.47	266,177	No	4	S	Direct
Common Stock	Acquisiton	2022-02-16	12,187	$6.28	278,364	No	4	M	Direct
Common Stock	Disposition	2022-02-16	12,187	$43.70	266,177	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Deferred Stock Units	Disposition	2022-02-15	4,153	$0.00	4,153	$0.00
Common Stock	Restricted Stock Units	Acquisiton	2022-02-16	16,972	$0.00	16,972	$0.00
Common Stock	Stock Option (Right to Buy)	Acquisiton	2022-02-16	48,529	$0.00	48,529	$44.19
Common Stock	Stock Option (Right to Buy)	Disposition	2022-02-16	12,187	$0.00	12,187	$6.28

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
4,153	2023-02-15	No	4	M	Direct
16,972	2026-02-16	No	4	A	Direct
48,529	2032-02-16	No	4	A	Direct
0	2022-02-27	No	4	M	Direct

Footnotes

Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.32 to $43.62, inclusive. The reporting person undertakes to provide upon request by the U.S.Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.50 to $43.84, inclusive. The reporting person undertakes to provide upon request by the U.S.Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.